Furthermore, Kaplan-Meier survival analysis revealed that high expression of TRPM6 and TRPM4 correlates with better overall survival in patients, indicating a favorable prognosis for COAD patients (36). The gene discussed is TRPM4; the disease is colon adenocarcinoma.